Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

Scientists at Oak Ridge National Laboratory and the University of Colorado Boulder used a gene-silencing tool and a large ...

Hyderabad: In a landmark moment for Indian agricultural science, ICAR–Indian Institute of Rice Research (IIRR) at ...

Rebecca Buckley, David Robinson II and Feng Zhang will be recognized Sunday in Wallace Wade Stadium. Their professional ...

India has become the first country to develop genome-edited rice varieties, DRR Dhan 100 (Kamala) and Pusa DST Rice 1. These ...

The CRISPR/Cas9 gene-editing technique has shown promise in fighting advanced colorectal cancer, according to results of the ...

Unity Biotechnology and Mammoth Biosciences are bpth turning toward cost-saving measures, prompting layoffs at both companies ...

Glioblastoma may be driven by 3D DNA folding patterns, not just mutations, offering new paths for treatment. A new ...

Genetic modification process has faced criticism, with many agriculturists and scientists raising concerns over its health, ...